76 related articles for article (PubMed ID: 3615436)
1. Protection by ebselen against endotoxin shock in rats or mice sensitized by galactosamine.
Konz KH; Tiegs G; Wendel A
Prog Clin Biol Res; 1987; 236A():281-8. PubMed ID: 3615436
[TBL] [Abstract][Full Text] [Related]
2. A novel biologically active seleno-organic compound--VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice.
Wendel A; Tiegs G
Biochem Pharmacol; 1986 Jul; 35(13):2115-8. PubMed ID: 3729968
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene-mediated liver injury.
Tiegs G; Wendel A
Biochem Pharmacol; 1988 Jul; 37(13):2569-73. PubMed ID: 2839197
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice.
Tiegs G; Wolter M; Wendel A
Biochem Pharmacol; 1989 Feb; 38(4):627-31. PubMed ID: 2465008
[TBL] [Abstract][Full Text] [Related]
5. Increased sinusoidal efflux of reduced and oxidized glutathione in rats with endotoxin/D-galactosamine hepatitis.
Irita K; Okabe H; Koga A; Kurosawa K; Tagawa K; Yamakawa M; Yoshitake J; Takahashi S
Circ Shock; 1994 Mar; 42(3):115-20. PubMed ID: 8025975
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of E3330, a novel quinone derivative, in galactosamine-induced hepatitis in rats.
Nagakawa J; Hirota K; Hishinuma I; Miyamoto K; Sonoda J; Yamanaka T; Katayama K; Yamatsu I
J Pharmacol Exp Ther; 1993 Jan; 264(1):496-500. PubMed ID: 8423547
[TBL] [Abstract][Full Text] [Related]
7. Protection against endotoxin-induced foetal resorption in mice by desferrioxamine and ebselen.
Gower JD; Baldock RJ; O'Sullivan AM; Doré CJ; Coid CR; Green CJ
Int J Exp Pathol; 1990 Aug; 71(4):433-40. PubMed ID: 2205283
[TBL] [Abstract][Full Text] [Related]
8. Ebselen protects mice against T cell-dependent, TNF-mediated apoptotic liver injury.
Tiegs G; Küsters S; Künstle G; Hentze H; Kiemer AK; Wendel A
J Pharmacol Exp Ther; 1998 Dec; 287(3):1098-104. PubMed ID: 9864298
[TBL] [Abstract][Full Text] [Related]
9. LPS challenge in D-galactosamine-sensitized mice accounts for caspase-dependent fulminant hepatitis, not for septic shock.
Mignon A; Rouquet N; Fabre M; Martin S; Pagès JC; Dhainaut JF; Kahn A; Briand P; Joulin V
Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1308-15. PubMed ID: 10194182
[TBL] [Abstract][Full Text] [Related]
10. Granulocyte colony-stimulating factor treatment protects rodents against lipopolysaccharide-induced toxicity via suppression of systemic tumor necrosis factor-alpha.
Görgen I; Hartung T; Leist M; Niehörster M; Tiegs G; Uhlig S; Weitzel F; Wendel A
J Immunol; 1992 Aug; 149(3):918-24. PubMed ID: 1378868
[TBL] [Abstract][Full Text] [Related]
11. Biological activities and clinical potential of Ebselen.
Parnham MJ
Adv Exp Med Biol; 1990; 264():193-7. PubMed ID: 2244495
[No Abstract] [Full Text] [Related]
12. Evidence for the involvement of a reperfusion injury in galactosamine/endotoxin-induced hepatitis in mice.
Wendel A; Tiegs G; Werner C
Biochem Pharmacol; 1987 Aug; 36(16):2637-9. PubMed ID: 3606663
[TBL] [Abstract][Full Text] [Related]
13. Effects of preconditioning with ebselen on glutathione metabolism and stress protein expression.
Hoshida S; Aoki K; Nishida M; Yamashita N; Igarashi J; Hori M; Kuzuya T; Tada M
J Pharmacol Exp Ther; 1997 Jun; 281(3):1471-5. PubMed ID: 9190885
[TBL] [Abstract][Full Text] [Related]
14. Ebselen--an in vivo immune response modifier.
Wendel A; Kuesters S; Tiegs G
Biomed Environ Sci; 1997 Sep; 10(2-3):253-9. PubMed ID: 9315318
[TBL] [Abstract][Full Text] [Related]
15. Protection by seleno-organic compound, Ebselen, against acute gastric mucosal injury induced by ischemia-reperfusion in rats.
Ueda S; Yoshikawa T; Takahashi S; Naito Y; Oyamada H; Takemura T; Morita Y; Tanigawa T; Sugino S; Kondo M
Adv Exp Med Biol; 1990; 264():187-90. PubMed ID: 2244494
[No Abstract] [Full Text] [Related]
16. Hydrazine sulfate protects D-galactosamine-sensitized mice against endotoxin and tumor necrosis factor/cachectin lethality: evidence of a role for the pituitary.
Silverstein R; Turley BR; Christoffersen CA; Johnson DC; Morrison DC
J Exp Med; 1991 Feb; 173(2):357-65. PubMed ID: 1988538
[TBL] [Abstract][Full Text] [Related]
17. Single-dose ebselen does not afford sustained neuroprotection to rats subjected to severe focal cerebral ischemia.
Salom JB; Pérez-Asensio FJ; Burguete MC; Marín N; Pitarch C; Torregrosa G; Romero FJ; Alborch E
Eur J Pharmacol; 2004 Jul; 495(1):55-62. PubMed ID: 15219820
[TBL] [Abstract][Full Text] [Related]
18. Protection of mice against lethal endotoxemia by lipid X is mediated through inhibition of neutrophil function.
Lam C; Schütze E; Walzl H; Basalka E
Circ Shock; 1987; 22(4):311-21. PubMed ID: 2820606
[TBL] [Abstract][Full Text] [Related]
19. A link between extracellular reactive oxygen and endotoxin-induced release of tumour necrosis factor alpha in vivo.
Neihörster M; Inoue M; Wendel A
Biochem Pharmacol; 1992 Mar; 43(5):1151-4. PubMed ID: 1554388
[TBL] [Abstract][Full Text] [Related]
20. [Relation between hepatic energy metabolism and reduced glutathione concentration in endotoxin-injected rats].
Kosugi I; Ueda S; Gonda T; Okada K
Masui; 1983 Aug; 32(8):962-8. PubMed ID: 6663685
[No Abstract] [Full Text] [Related]
[Next] [New Search]
